The FDA reviewed Smith & Nephew’s pre-market approval application for its Birmingham metal-on-metal hip implant in 2006. At the same time, Wright Medical Group sought to block approval, alleging the clinical studies behind Smith & Nephew’s device only included data from a single physician’s case — the surgeon who invented the hip implant.
Despite the petition, the FDA awarded two pre-market approvals to Smith & Nephew, once in May 2006 and then in October 2006 for additional sizes, according to the report.
More Articles on Orthopedic Devices:
Breg Appoints Former Integra LifeSciences Exec to Board
FH Orthopedics Receives CE Mark Approval for Cervical Elastic Spine Disc
ISTO Technologies Names John Hart COO
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.